(Q44390228)

2 December 2017

title

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group (English)

1 reference

2 December 2017

Witchitz S

1

1 reference

2 December 2017

Cohen-Solal A

2

1 reference

2 December 2017

Dartois N

3

1 reference

2 December 2017

Weisslinger N

4

1 reference

2 December 2017

Juste K

5

1 reference

2 December 2017

Darmon JY

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Cardiology

2 December 2017

published in

1 reference

2 December 2017

volume

85

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

1467-1471

1 reference

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Celiprolol and the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Contrasting actions of celiprolol and metoprolol on cardiac performance in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Effects of beta-adrenergic blockade on survival of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Estimation of maximum oxygen uptake from clinical data: performance of the Specific Activity Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900796-7

10.1016/S0002-9149(00)00796-7

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference